$23.21
Today
as of Jul 22, 16:48 ET
Last 30 days
Recent Press Releases & News
Dyne Therapeutics Prices Upsized $375.2 Million Secondary Offering
Dyne Therapeutics Announces Pricing of Upsized $375 Million Public Offering of Common Stock
Why DYN Shares Are Down 10% After-Hours? Day After An FDA Win, Another Announcement Rocks Stock
Overview
52-week range
$8.06
$25
89% of range
Avg surprise (last 3)
-5.3%
Avg reaction (last 2)
+12.5%
100% positive
Latest IV / EM
86%
EM ±19.6% · $23 · Aug 21
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Mon May 11, 2026 | Mar/2026 | $-0.73 | $-0.74 | +1.4% | +30.5% | +4.8% | earnings |
| Tue Sep 30, 2025 | Sep 2025 | $-0.76 | — | — | — | — | financials |
| Mon Jul 28, 2025 | Jun/2025 | $-0.97 | $-0.99 | +2.0% | — | — | earnings |
| Thu May 8, 2025 | Mar/2025 | $-1.05 | $-0.88 | -19.3% | — | +20.2% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $-0.96 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $-0.70 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $-0.81 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $-0.99 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $-1.08 | — | — | — | — | financials |
Upcoming
| Date | Fiscal | Time | EPS Est | LY EPS | YoY %Δ |
|---|---|---|---|---|---|
| Mon Jul 27, 2026 | Jun/2026 | OTHER | -$0.74 | -$0.97 | +23.7% |
Financials
Income statement (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of revenue | — | — | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | $-125M | — | $-114M | $-116M | $-122M | — | $-106M | $-72M |
| Net income | $-121M | — | $-108M | $-111M | $-115M | — | $-97M | $-65M |
| EPS (diluted) | $-0.73 | — | $-0.76 | $-0.97 | $-1.05 | — | $-0.96 | $-0.70 |
Balance sheet (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $753M | $893M | $574M | $485M | $472M | $435M | $532M | $608M |
| Inventory | — | — | — | — | — | — | — | — |
| Total current assets | $1.02B | $1.13B | $806M | $698M | $690M | $659M | $736M | $792M |
| Total assets | $1.08B | $1.19B | $867M | $729M | $721M | $691M | $769M | $826M |
| Long-term debt | — | — | — | — | — | — | — | — |
| Total liabilities | $215M | $215M | $175M | $158M | $52M | $61M | $63M | $51M |
| Total equity | $865M | $972M | $692M | $571M | $669M | $630M | $706M | $775M |